Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
29
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
$51.50
Seasonality Move:
5.96%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight buying pressure.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54 | Sell |
| 20-day SMA: | 56.78 | Sell |
| 50-day SMA: | 59.76 | Sell |
| 200-day SMA: | 59.78 | Sell |
| 8-day EMA: | 53.61 | Sell |
| 20-day EMA: | 55.94 | Sell |
| 50-day EMA: | 58.68 | Sell |
| 200-day EMA: | 59.53 | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.07 | Sell |
| Relative Strength Index (14 RSI): | 32.14 | Sell |
| Chaikin Money Flow: | 2201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.46 - 59) | Sell |
| Bollinger Bands (100): | (57.86 - 66.12) | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 51.41 while BIB 8-day simple moving average is 54.00, which is a Sell signal.
-
The stock price of BIB is 51.41 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 56.78, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 59.76 while BIB share price is 51.41, making it a Sell technically.
-
BIB stock price is 51.41 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 59.78, creating a Sell signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
29
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a SellThe current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $51.41. The Score for BIB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
51.41
Share Volume:
7K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
47.20
Sell
29
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?The ProShares Ultra Nasdaq Biotechnology stock price is 51.41 USD today.
-
Will BIB stock go up or go down?ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators
-
Is ProShares Ultra Nasdaq Biotechnology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 51.41 while BIB 8-day exponential moving average is 53.61, which is a Sell signal.
-
The stock price of BIB is 51.41 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 55.94, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 58.68 while BIB share price is 51.41, making it a Sell technically.
-
BIB stock price is 51.41 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 59.53, creating a Sell signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
-
BIB Moving Average Covergence Divergence (MACD) indicator is -2.07, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
-
ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 32.14, which suggest ProShares Ultra Nasdaq Biotechnology is oversold
-
The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (53.46 - 59), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
-
The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (57.86 - 66.12), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.